What is Nurix Therapeutics, Inc.'s change in other assets?

Nurix Therapeutics, Inc. (NRIX) reported change in other assets of -$1.29M in Q4 2025.

How has Nurix Therapeutics, Inc.'s change in other assets changed year-over-year?

Nurix Therapeutics, Inc.'s change in other assets decreased by 120.6% year-over-year, from $6.25M to -$1.29M.

What does change in other assets mean?

Change in miscellaneous assets affecting operating cash flow.

Nurix Therapeutics, Inc. NRIX Change in Other Assets

Change in Other Assets at other companies

Kymera TherapeuticsKYMR

$3.57M+228%

Monte Rosa Therapeutics, Inc.GLUE

$2.92M+72,925%

Stoke Therapeutics, Inc.STOK

$3.59M+192%

Viridian Therapeutics, Inc.VRDN

$2.33M+919%

Nuvation BioNUVB

-$3.78M-2,509%

Celldex TherapeuticsCLDX

-$6.28M-239%

Other financials

Income statement

See full

Revenue$6.3M-66.1%

Operating income-$92.5M-47.1%

Net income-$87.2M-54.7%

EPS (diluted)-$0.79-17.9%

Balance sheet

See full

Cash & equivalents$72.2M-6.1%

Total debt$58.7M+120%

Total equity$480.9M0.0%

Total assets$636.1M+3.4%

Cash flow

See full

Operating cash flow-$71.9M-17.7%

CapEx$1.0M-70.0%

Free cash flow-$73.0M-13.0%

Valuation

See full

Market cap$1.95B+40.1%

Enterprise value$1.94B+45.1%

P/S27.2×+2.5×

Profitability

See full

Operating margin-439.3%+35.3pp

Net margin-411.4%+52.7pp

FCF margin-378.7%+24.1pp

Returns & leverage

See full

Return on equity-61.4%-2.5pp

Debt / equity0.1×+0.1×

Current ratio6×-0.3×

Where this comes from

Reported directly by Nurix Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nurix Therapeutics, Inc.'s change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nurix Therapeutics, Inc.'s change in other assets?: Nurix Therapeutics, Inc. (NRIX) reported change in other assets of -$1.29M in Q4 2025.
How has Nurix Therapeutics, Inc.'s change in other assets changed year-over-year?: Nurix Therapeutics, Inc.'s change in other assets decreased by 120.6% year-over-year, from $6.25M to -$1.29M.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.